BRPI0908727A2 - Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis - Google Patents

Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis

Info

Publication number
BRPI0908727A2
BRPI0908727A2 BRPI0908727-3A BRPI0908727A BRPI0908727A2 BR PI0908727 A2 BRPI0908727 A2 BR PI0908727A2 BR PI0908727 A BRPI0908727 A BR PI0908727A BR PI0908727 A2 BRPI0908727 A2 BR PI0908727A2
Authority
BR
Brazil
Prior art keywords
diols
propane
phenyl
ethyl
amino
Prior art date
Application number
BRPI0908727-3A
Other languages
English (en)
Inventor
Gottfried Sedelmeier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0908727A2 publication Critical patent/BRPI0908727A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0908727-3A 2008-03-19 2009-03-17 Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis BRPI0908727A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153033 2008-03-19
PCT/EP2009/053163 WO2009115534A1 (en) 2008-03-19 2009-03-17 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl] propane-1, 3-diols

Publications (1)

Publication Number Publication Date
BRPI0908727A2 true BRPI0908727A2 (pt) 2015-07-28

Family

ID=40848446

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908727-3A BRPI0908727A2 (pt) 2008-03-19 2009-03-17 Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis

Country Status (17)

Country Link
US (2) US8809571B2 (pt)
EP (1) EP2268603B1 (pt)
JP (2) JP5698118B2 (pt)
KR (1) KR101641742B1 (pt)
CN (1) CN101959845A (pt)
AR (1) AR072776A1 (pt)
AU (1) AU2009226975B2 (pt)
BR (1) BRPI0908727A2 (pt)
CA (1) CA2717934C (pt)
ES (1) ES2536552T3 (pt)
IL (1) IL208019A (pt)
MX (1) MX2010009931A (pt)
PL (1) PL2268603T3 (pt)
PT (1) PT2268603E (pt)
RU (1) RU2529474C2 (pt)
WO (1) WO2009115534A1 (pt)
ZA (1) ZA201006058B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809571B2 (en) * 2008-03-19 2014-08-19 Novartis Ag Process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
EP2896609B1 (en) * 2009-07-24 2018-06-27 ratiopharm GmbH Crystalline fingolimod citrate for the treatment of relapsing-remitting multiple sclerosis
WO2012071524A1 (en) 2010-11-24 2012-05-31 Ratiopharm Gmbh Arylsulfonate salts of fingolimod and processes for preparation thereof
WO2012146980A2 (en) 2011-04-29 2012-11-01 Dr. Reddy's Laboratories Ltd. Preparation of fingolimod and its salts
CZ2012406A3 (cs) 2012-06-15 2013-12-27 Zentiva, K.S. Způsob výroby fingolimodu založený na otevírání aziridinového kruhu
JP7078190B1 (ja) 2022-01-31 2022-05-31 トヨタ自動車株式会社 保持部材、射出装置、及び差し込み方向ガイド方法
JP7268779B1 (ja) 2022-01-31 2023-05-08 トヨタ自動車株式会社 保持部材

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0627406T3 (da) 1992-10-21 1999-07-12 Taito Co 2-Amino-1,3-propandiolforbindelser og immunundertrykkende midler
IT1265101B1 (it) * 1993-07-23 1996-10-30 Erba Carlo Spa Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
ES2237970T3 (es) * 1998-11-11 2005-08-01 Novartis Ag Produccion de 2-amino-2-(2-(4-alquil c2-20-fenil)etil)propano-1,3-dioles.
CN1144779C (zh) * 1999-03-11 2004-04-07 杭州中美华东制药有限公司 制备2-[2-(4-烷基苯基)-乙基]-2-氨基-丙二醇的方法以及其中制得的中间产物
CN1169768C (zh) * 2002-04-26 2004-10-06 中国科学院上海有机化学研究所 （4－炔基）－芳香酮酸类化合物、合成方法及应用
JP3972021B2 (ja) 2003-05-28 2007-09-05 東京応化工業株式会社 プラズマディスプレイ前面板製造用未焼成積層体およびプラズマディスプレイ前面板の製造方法
AU2006214314B2 (en) * 2005-02-14 2012-02-09 University Of Virginia Patent Foundation Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups
TW200702326A (en) 2005-05-31 2007-01-16 Mitsubishi Pharma Corp 2-aminobutanol compound and its pharmaceutical use
US8809571B2 (en) * 2008-03-19 2014-08-19 Novartis Ag Process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein

Also Published As

Publication number Publication date
CN101959845A (zh) 2011-01-26
IL208019A0 (en) 2010-12-30
CA2717934C (en) 2017-07-18
RU2010142397A (ru) 2012-04-27
IL208019A (en) 2015-10-29
AR072776A1 (es) 2010-09-22
ZA201006058B (en) 2011-05-25
JP2011515364A (ja) 2011-05-19
CA2717934A1 (en) 2009-09-24
US20140094625A1 (en) 2014-04-03
RU2529474C2 (ru) 2014-09-27
ES2536552T3 (es) 2015-05-26
EP2268603B1 (en) 2015-04-22
AU2009226975A1 (en) 2009-09-24
KR20100127279A (ko) 2010-12-03
JP2015028056A (ja) 2015-02-12
US8809571B2 (en) 2014-08-19
JP5955364B2 (ja) 2016-07-20
JP5698118B2 (ja) 2015-04-08
EP2268603A1 (en) 2011-01-05
MX2010009931A (es) 2010-09-30
KR101641742B1 (ko) 2016-07-21
PL2268603T3 (pl) 2015-07-31
US9133096B2 (en) 2015-09-15
US20110015425A1 (en) 2011-01-20
PT2268603E (pt) 2015-06-08
WO2009115534A1 (en) 2009-09-24
AU2009226975B2 (en) 2012-09-06

Similar Documents

Publication Publication Date Title
BRPI0910910A2 (pt) processo para preparar um composto
BRPI0910911A2 (pt) processo para preparar um composto
BRPI0919871A2 (pt) processo para preparação de acroleína a partir de glicerol
BRPI1014306B8 (pt) processo para preparar um gel reticulado
BRPI0913977A2 (pt) Processo para produzir um hidrolisado compreendendo glicose
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
BRPI0820851A2 (pt) Processo para preparar microcápsulas
BRPI1012018A2 (pt) processo para preparar um composto
BRPI0810067A2 (pt) Processo para a preparação de capecitabina
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI0911898A2 (pt) processo para preparar compostos, e, composto.
BRPI0909280A2 (pt) processo para preparar uretanos.
BRPI0922186A2 (pt) processo para preparar um isocianato, e , isocianato
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI0921420A2 (pt) processo para preparar compostos
BRPI0912558A2 (pt) Processo para a preparação de amidas
BR112012001462A2 (pt) processo para preparar metil mercaptano.
BRPI1008987A2 (pt) processo para preparar 3,3,3-trifluoropropeno
BRPI0921882A2 (pt) processo para fabricar um composto.
BRPI0908727A2 (pt) Processo para preparar 2-amino-2-[2-(4-c3-c21-alquil-fenil)etil] propano-1,3-dióis
BRPI0917836A2 (pt) processo para preparar uretanos
BRPI0911992A2 (pt) processo para preparação de bifenilanilidas substituídas
BRPI0811315A2 (pt) Processo para a preparação de um composto

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]